AU2001264313A1 - Pyrazolopyridine compounds and use thereof as drugs - Google Patents

Pyrazolopyridine compounds and use thereof as drugs

Info

Publication number
AU2001264313A1
AU2001264313A1 AU2001264313A AU6431301A AU2001264313A1 AU 2001264313 A1 AU2001264313 A1 AU 2001264313A1 AU 2001264313 A AU2001264313 A AU 2001264313A AU 6431301 A AU6431301 A AU 6431301A AU 2001264313 A1 AU2001264313 A1 AU 2001264313A1
Authority
AU
Australia
Prior art keywords
drugs
pyrazolopyridine compounds
pyrazolopyridine
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001264313A
Inventor
Hisashi Kawasaki
Koichi Ozawa
Kazuhiko Yamamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Tobacco Inc
Original Assignee
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2000185067A external-priority patent/JP2004123537A/en
Priority claimed from JP2001070593A external-priority patent/JP2004123539A/en
Application filed by Japan Tobacco Inc filed Critical Japan Tobacco Inc
Publication of AU2001264313A1 publication Critical patent/AU2001264313A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
AU2001264313A 2000-06-20 2001-06-18 Pyrazolopyridine compounds and use thereof as drugs Abandoned AU2001264313A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000185067A JP2004123537A (en) 2000-06-20 2000-06-20 Pyrazolopyridine compound and its pharmaceutical application
JP2000-185067 2000-06-20
JP2001-070593 2001-03-13
JP2001070593A JP2004123539A (en) 2001-03-13 2001-03-13 New pyrazolopyridine compound and medicinal application
PCT/JP2001/005187 WO2001098301A1 (en) 2000-06-20 2001-06-18 Pyrazolopyridine compounds and use thereof as drugs

Publications (1)

Publication Number Publication Date
AU2001264313A1 true AU2001264313A1 (en) 2002-01-02

Family

ID=26594297

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001264313A Abandoned AU2001264313A1 (en) 2000-06-20 2001-06-18 Pyrazolopyridine compounds and use thereof as drugs

Country Status (2)

Country Link
AU (1) AU2001264313A1 (en)
WO (1) WO2001098301A1 (en)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1383778B1 (en) 2001-01-30 2009-10-21 University Of Virginia Patent Foundation Agonists and antagonists of sphingosine-1-phosphate receptors
EP1424078A4 (en) * 2001-09-04 2009-03-25 Ono Pharmaceutical Co Remedies for respiratory diseases comprising sphingosine-1-phosphate receptor controller
EP1522314B1 (en) * 2002-06-26 2014-03-05 Ono Pharmaceutical Co., Ltd. Remedies for diseases caused by vascular contraction or dilation
EP1548003A4 (en) 2002-09-19 2006-06-07 Kyorin Seiyaku Kk Amino alcohol derivative, addition salt thereof, and immunosuppressant
DK1602660T3 (en) 2003-02-18 2011-05-23 Kyorin Seiyaku Kk Aminophosphonic acid derivatives, addition salts thereof, and S1P receptor modulators
GB0308511D0 (en) * 2003-04-14 2003-05-21 Astex Technology Ltd Pharmaceutical compounds
EP1698375B1 (en) 2003-12-25 2014-04-02 Ono Pharmaceutical Co., Ltd. Azetidine ring compounds and drugs comprising the same
RU2006134021A (en) 2004-02-27 2008-04-10 Ф.Хоффманн-Ля Рош Аг (Ch) Heteroaryl-Condensed Pyrazole Derivatives
KR100843526B1 (en) 2004-02-27 2008-07-03 에프. 호프만-라 로슈 아게 Fused derivatives of pyrazole
BRPI0508107A (en) 2004-02-27 2007-07-17 Hoffmann La Roche indazole derivatives and pharmaceutical compositions containing the same
DE602005027074D1 (en) 2004-07-16 2011-05-05 Kyorin Seiyaku Kk METHOD FOR EFFECTIVELY APPLYING A MEDICAMENT AND METHOD FOR PREVENTING SIDE EFFECTS
ES2615498T3 (en) 2004-10-12 2017-06-07 Kyorin Pharmaceutical Co., Ltd. Process for producing 2-amino-2- [2- [4- (3-benzyloxyphenylthio) -2-chlorophenyl] ethyl] -1,3-propanediol hydrochloride
BRPI0615442A2 (en) 2005-08-25 2011-05-17 Hoffmann La Roche p38 map kinase inhibitors and methods for using them
WO2007043433A1 (en) 2005-10-07 2007-04-19 Kyorin Pharmaceutical Co., Ltd. Therapeutic agent for liver disease containing 2-amino-1,3-propanediol derivative as active ingredient and therapeutic method for liver disease
TWI389683B (en) 2006-02-06 2013-03-21 Kyorin Seiyaku Kk A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient
CN101460458A (en) 2006-02-15 2009-06-17 阿勒根公司 Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
WO2007095561A2 (en) * 2006-02-15 2007-08-23 Allergan, Inc. Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
CA2645137A1 (en) 2006-03-07 2007-09-13 James F. Blake Heterobicyclic pyrazole compounds and methods of use
EP2053038B1 (en) 2006-08-08 2016-10-05 Kyorin Pharmaceutical Co., Ltd. Amino alcohol derivative and immunosuppressive agent having same as an active ingredient
ME02095B (en) 2006-08-08 2014-06-30 Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient
US8524917B2 (en) 2007-01-11 2013-09-03 Allergan, Inc. 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
WO2008089015A1 (en) 2007-01-11 2008-07-24 Allergan, Inc. 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
US20090004207A1 (en) * 2007-06-08 2009-01-01 Timothy Tun Hla Methods and Compositions for Inhibiting Pathological Angiogenesis in the Eye
WO2009085847A1 (en) 2008-01-03 2009-07-09 Allergan, Inc. Tetrahydroindoles having sphingosine-1-phosphate receptor activity
WO2010030976A2 (en) * 2008-09-12 2010-03-18 University Of Connecticut Methods and compositions for inhibiting atherosclerosis and vascular inflammation
GB0908394D0 (en) 2009-05-15 2009-06-24 Univ Leuven Kath Novel viral replication inhibitors
GB0913636D0 (en) 2009-08-05 2009-09-16 Univ Leuven Kath Novel viral replication inhibitors
JP2013506003A (en) * 2009-09-29 2013-02-21 アラーガン インコーポレイテッド Fused ring pyridine compounds as subtype-selective modulators of sphingosine-1-phosphate-2 (S1P2) receptors
ES2460915T3 (en) * 2009-12-21 2014-05-16 Novartis Ag Pyridines fused with disubstituted heteroaryl
WO2011159864A1 (en) * 2010-06-17 2011-12-22 Bracco Imaging S.P.A. Jte013 analogs and methods of making and using same
CN105859590B (en) * 2010-10-12 2018-01-02 日本曹达株式会社 Aryloxy group carbamide compound and noxious organism control agent
CA2817165A1 (en) 2010-11-15 2012-05-24 Patrick Chaltin Novel antiviral compounds
ES2689132T3 (en) 2011-09-29 2018-11-08 Ono Pharmaceutical Co., Ltd. Phenyl derivative
WO2013148460A1 (en) * 2012-03-26 2013-10-03 Swenson Rolf E Novel sphingosine 1-phosphate receptor antagonists
US9181261B2 (en) * 2012-05-22 2015-11-10 Merck Sharp & Dohme Corp. TrkA kinase inhibitors, compositions and methods thereof
EP2867236B1 (en) 2012-06-29 2017-06-14 Pfizer Inc Novel 4-(substituted-amino)-7h-pyrrolo[2,3-d]pyrimidines as lrrk2 inhibitors
KR102243426B1 (en) 2013-03-26 2021-04-21 오노 야꾸힝 고교 가부시키가이샤 A medicine comprising phenyl derivatives
NO2980072T3 (en) 2013-03-26 2018-09-22
JP6487921B2 (en) 2013-12-17 2019-03-20 ファイザー・インク Novel 3,4-disubstituted-1H-pyrrolo [2,3-b] pyridines and 4,5-disubstituted-7H-pyrrolo [2,3-c] pyridazines as LRRK2 inhibitors
AU2015271605B2 (en) 2014-06-02 2019-11-14 Dalhousie University Treatment of familial exudative vitreoretinopathy through S1PR2 inhibition
US10487082B2 (en) 2015-06-01 2019-11-26 Dalhousie University S1PR2 antagonists and uses therefor
US10858358B2 (en) 2015-06-01 2020-12-08 Dalhousie University S1PR2 antagonists and uses therefor
AU2016273436B2 (en) * 2015-06-01 2021-01-28 Dalhousie University S1PR2 antagonists and uses therefor
RU2722149C1 (en) 2015-09-14 2020-05-27 Пфайзер Инк. New derivatives of imidazo [4,5-c] quinolines and imidazo [4,5-c] [1,5] naphthyridines as lrrk2 inhibitors
JOP20190024A1 (en) 2016-08-26 2019-02-19 Gilead Sciences Inc Substituted pyrrolizine compounds and uses thereof
WO2019002624A1 (en) * 2017-06-30 2019-01-03 Kleuser, Burkhard Medicaments for treating inflammatory bowel diseases
US10836769B2 (en) 2018-02-26 2020-11-17 Gilead Sciences, Inc. Substituted pyrrolizine compounds and uses thereof
CN112203509A (en) * 2018-05-25 2021-01-08 国立大学法人京都大学 Method for suppressing freeze damage and composition for preventing freeze damage
WO2023283921A1 (en) * 2021-07-16 2023-01-19 北京深蓝泰医药科技有限公司 Dpd inhibitor, and pharmaceutical composition and use thereof
WO2024077036A1 (en) * 2022-10-07 2024-04-11 Scorpion Therapeutics, Inc. Methods for treating cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6121M (en) * 1966-01-12 1968-06-17
US4260614A (en) * 1980-02-08 1981-04-07 E. R. Squibb & Sons, Inc. 4-(2-(1H-Imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxypyrazolo(3,4-b)pyridines
IT1154024B (en) * 1982-09-22 1987-01-21 Lepetit Spa PRIDINICAL DERIVATIVES AND PROCEDURE FOR THEIR PRODUCTION
US4822799A (en) * 1988-01-27 1989-04-18 Sandoz Pharm. Corp. Pyrazolopyridine analogs of mevalonolactone and derivatives thereof useful for inhibiting cholesterol biosynthesis in mammals
US5024999A (en) * 1988-04-26 1991-06-18 Nissan Chemical Industries Ltd. Pyrazolopyridine type mevalonolactones useful as pharmaeuticals
JP3130342B2 (en) * 1991-10-04 2001-01-31 日産化学工業株式会社 Atherosclerotic intimal thickening inhibitor
KR20000035869A (en) * 1996-08-30 2000-06-26 가마쿠라 아키오 Preventives/remedies for muscle tissue degenerations

Also Published As

Publication number Publication date
WO2001098301A1 (en) 2001-12-27

Similar Documents

Publication Publication Date Title
AU2001264313A1 (en) Pyrazolopyridine compounds and use thereof as drugs
AU2001280188A1 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AU2001277741A1 (en) 2-aminopyridine compounds and use thereof as drugs
AU2001277754A1 (en) Proline derivatives and use thereof as drugs
AU763356C (en) Fused-ring compounds and use thereof as drugs
AU2001256184A1 (en) 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases
IL150734A0 (en) Azaindole derivatives and pharmaceutical compositions containing the same
AU2001287898A1 (en) Pyrazolopyridines and pyrazolopyridazines as antidiabetics
AU5326100A (en) Pharmaceutical compositions and methods for use
AU2002354476A1 (en) Pyrazolopyridine derivatives and medicinal use thereof
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
AU2002221099A1 (en) Combination drugs
AUPP672198A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AU1053501A (en) Polyazanaphthalene compound and medicinal use thereof
AUPQ462299A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AU4432001A (en) Trityl-type compounds and their use
AUPR916301A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AU2001260236A1 (en) Restricted use syringe
AU2000231564A1 (en) Phosphororganic compounds and the use thereof
AUPR606401A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AU2001284084A1 (en) Polyfluoroalkyltriazole derivatives, preparation and therapeutic use thereof
AU2001262928A1 (en) Pharmaceutical compositions and their use
AU2002308105A1 (en) Benzoaxathiepin derivatives and their use as medicines
AU2001259564A1 (en) Pharmaceutical compositions and methods for use
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof